Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125789372 | 12578937 | 2 | F | 20160707 | 20160721 | 20160721 | EXP | PHHY2016AU093602 | SANDOZ | 0.00 | M | Y | 0.00000 | 20160721 | MD | AU | AU |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125789372 | 12578937 | 1 | PS | CICLOSPORIN | CYCLOSPORINE | 1 | Unknown | U | 65017 | ||||||||||
125789372 | 12578937 | 2 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | U | 0 | ||||||||||
125789372 | 12578937 | 3 | SS | AZATHIOPRINE. | AZATHIOPRINE | 1 | Unknown | U | 0 | ||||||||||
125789372 | 12578937 | 4 | SS | SECUKINUMAB | SECUKINUMAB | 1 | Unknown | 300 MG, UNK | U | 0 | 300 | MG | |||||||
125789372 | 12578937 | 5 | SS | MYCOPHENOLATE | MYCOPHENOLIC ACID | 1 | Unknown | U | 0 | ||||||||||
125789372 | 12578937 | 6 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | U | 0 | ||||||||||
125789372 | 12578937 | 7 | SS | ANAKINRA | ANAKINRA | 1 | Unknown | U | 0 | INJECTION | |||||||||
125789372 | 12578937 | 8 | SS | DAPSONE. | DAPSONE | 1 | Unknown | U | 0 | ||||||||||
125789372 | 12578937 | 9 | SS | COLCHICINE. | COLCHICINE | 1 | Unknown | U | 0 | ||||||||||
125789372 | 12578937 | 10 | SS | POTASSIUM IODIDE. | POTASSIUM IODIDE | 1 | Unknown | U | 0 | ||||||||||
125789372 | 12578937 | 11 | SS | RITUXIMAB | RITUXIMAB | 1 | Unknown | 1 G, (2 DOSES) | 0 | 1 | G | ||||||||
125789372 | 12578937 | 12 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | 30 TO 50 MG DAILY | U | 0 | 50 | MG | |||||||
125789372 | 12578937 | 13 | C | INFLIXIMAB | INFLIXIMAB | 1 | Unknown | U | 0 | ||||||||||
125789372 | 12578937 | 14 | C | TOCILIZUMAB | TOCILIZUMAB | 1 | Unknown | U | 0 | ||||||||||
125789372 | 12578937 | 15 | C | WARFARIN | WARFARIN | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125789372 | 12578937 | 1 | Neutrophilic dermatosis |
125789372 | 12578937 | 2 | Neutrophilic dermatosis |
125789372 | 12578937 | 3 | Neutrophilic dermatosis |
125789372 | 12578937 | 4 | Neutrophilic dermatosis |
125789372 | 12578937 | 5 | Neutrophilic dermatosis |
125789372 | 12578937 | 6 | Neutrophilic dermatosis |
125789372 | 12578937 | 7 | Neutrophilic dermatosis |
125789372 | 12578937 | 8 | Neutrophilic dermatosis |
125789372 | 12578937 | 9 | Neutrophilic dermatosis |
125789372 | 12578937 | 10 | Neutrophilic dermatosis |
125789372 | 12578937 | 11 | Neutrophilic dermatosis |
125789372 | 12578937 | 12 | Neutrophilic dermatosis |
125789372 | 12578937 | 13 | Neutrophilic dermatosis |
125789372 | 12578937 | 14 | Neutrophilic dermatosis |
125789372 | 12578937 | 15 | Deep vein thrombosis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125789372 | 12578937 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125789372 | 12578937 | Bone marrow failure | |
125789372 | 12578937 | Cataract | |
125789372 | 12578937 | Drug ineffective | |
125789372 | 12578937 | Glucose tolerance impaired | |
125789372 | 12578937 | Injection site reaction | |
125789372 | 12578937 | Ulcer | |
125789372 | 12578937 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125789372 | 12578937 | 11 | 2015 | 0 |